Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Executive Search and Leadership Advisory

EURORDIS recognises Orphan Europe and Swedish Orphan Biovitrum (SOBI) with awards

Authored by Karl Simpson

Read the full article…

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , | Leave a comment

Novimmune sees immunotherapy and orphan focus attract new capital

Authored by Karl Simpson

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

UK immunotherapy biotech gains orphan drug designation from FDA

Authored by Karl Simpson

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , | Leave a comment

David Roth appointed Chief Medical Officer of Infinity

Authored by Karl Simpson

Read the full article…

Posted in Executive Appointments, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , | Leave a comment

Karolinska Development announces new Chief Financial Officer

Authored by Karl Simpson

Read the full article…

Posted in Executive Appointments, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment

BioBlast founders ramp towards another IPO for rare disease company

Authored by Karl Simpson

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , | Leave a comment

New Enterprise Associates backs veteran rare diseases executive team

Authored by Karl Simpson

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , | Leave a comment

Kiadis rides high after positive clinical data

Authored by James Sheppard

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Biosimilars – is global development a reality?

GN photo

Read the full article…

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

Amal Therapeutics raises seed funding for cancer immunotherapy

Authored by James Sheppard

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap